Mullighan office (IMAGE)

St. Jude Children's Research Hospital

Mullighan office

Caption

Findings published today in Nature Cancer from Charles Mullighan, MBBS (Hons), MSc, MD, deputy director of the St. Jude Comprehensive Cancer Center, Department of Pathology, and collaborators show that the stage at which B cells transform into leukemic cells can impact treatment outcomes for B-cell acute lymphoblastic leukemia (B-ALL).

Credit

St. Jude Children's Research Hospital

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.